Morning Overview on MSN
Single-cell breakthrough decodes transcriptome, epigenome & 3D genome at once
A team led by Professor Inkyung Jung from the Department of Biological Sciences at KAIST, working with Professor Yarui Diao’s ...
Researchers have developed a capsule-based method that makes it possible to analyze the same cell through multiple experimental steps. The technology overcomes a long-standing limitation in cell ...
Advances in genomics and transcriptomics continue to catapult basic and clinical research into a new era. A more comprehensive examination of genomic and transcriptional states allows for ...
Researchers have developed a capsule-based method that makes it possible to analyse the same cell through multiple experimental steps. The technology overcomes a long-standing limitation in cell ...
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient's cells.
Michael Junkin, PhD, leads the instrumentation for Elegen’s DNA synthesis platform. He has more than 15 years of experience in the field of microfluidics, having developed systems to study ...
Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results